Corporate Banner
Satellite Banner
Technology Networks Header
Saturday, August 02, 2014
Technology Networks
 
Register | Sign in
Home Page > Latest Webcasts
  Webcasts
Scientific News
Collaboration Leads to Possible Shortcut to New Drugs
The reaction, reported in Science, demonstrates how a carboxylic acid can be transformed into a very reactive site through use of a novel photoredox catalyst.
Catalysts That Mimic Enzymes Could Revolutionize Pharmaceutical Manufacturing
Structures made of polymer chains allow the catalysts to work in water.
Discovery of How Taxol Works Could Lead to Better Anticancer Drugs
The drug’s interference with the normal function of microtubules could help in designing better anticancer drugs.
Chemists Discover Cancer Drug Candidate Structure
Chemists at The Scripps Research Institute have determined the correct structure of a highly promising anticancer compound approved by the U.S. FDA for clinical trials in cancer patients.
Novel Drug Targets for Allergy Identified
Researchers have identified several target molecules which are suitable for the development of new allergy drugs.
Drug Does Not Improve Set of Cardiovascular Outcomes for Diastolic Heart Failure
NIH-supported study finds drug does appear to reduce hospitalizations for diastolic heart failure.
Entirely Novel Strategy to Molecular Anticancer Therapy Tricks Malignant Cells
New drug prevents tumour growth by inhibiting the nucleotide sanitizing enzyme MTH1.
New Trial of Personalized Cancer Treatment Begins in Oxford
Phase I trial in Oxford will investigate a new drug, called CXD101.
Flow Microreactor Synthesis in Organo-Fluorine Chemistry
This review focuses on successful examples on synthesis and reactions of fluorine-containing molecules by the use of flow microreactor systems.
Reviewing Colchicaceae Alkaloids - Perspectives of Evolution on Medicinal Chemistry
Researchers have shown how thinking about evolution can influence selection of plant material in drug lead discovery.
Scroll Up
Scroll Down
Return
vHTS versus HTS in Ion Channel Research
Stefan Tasler, Senior Scientist, 4SC, speaking at Screening Europe 2009
Date Posted: Thursday, February 11, 2010
Print Page

For access to this article, enter your email address to instantly recieve a Password Reset link.

Please enter your email address below:

Existing users please Sign In here. Don't have an account? Register Here for free access.

Don't have an account? | Register Here



Inhibition of Interleukin-17 in Inflammatory Bowel Disease and Efficacy in Systemic Lupus Erythematosus Demonstrated
4SC AG, a drug discovery and development company focused on autoimmune and cancer indications, today announced that two scientific publications on vidofludimus (4SC-101), 4SC's lead autoimmune small-molecule drug, have been published in international peer-reviewed journals.
Wednesday, April 28, 2010
4SC AG Receives Research Grant from the Bavarian Research Foundation
4SC AG, a drug discovery and development company, today announced that it has received, as part of a consortium, a research grant from the Bavarian Research Foundation (Bayerische Forschungsstiftung) to fund the discovery of protein kinase inhibitors as potential therapies for the treatment of herpes viruses.
Thursday, December 10, 2009
 
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv